NR3C1 and COVID-19: Dexamethasone, a synthetic adrenal corticosteroid that exerts anti-inflammatory and immunosuppressive effects through the glucocorticoid receptor (GR), was demonstrated to relieve inflammation in COVID-19 by pro-resolving lipid mediators (111).